HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era

BACKGROUND: Well-tolerated, highly effective HCV treatment, known as direct-acting antivirals (DAAs), is now recommended for all people living with HCV, providing the tools for HCV elimination. We sought to understand treatment barriers among low-income HIV/HCV coinfected patients and providers with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Public Health (Oxf)
Autori principali: Nápoles, Tessa M, Batchelder, Abigail W, Lin, Ada, Moran, Lissa, Johnson, Mallory O, Shumway, Martha, Luetkemeyer, Anne F, Peters, Marion G, Eagen, Kellene V, Riley, Elise D
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Short Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6923516/
https://ncbi.nlm.nih.gov/pubmed/31044248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pubmed/fdz045
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi